CNSP · CNS Pharmaceuticals, Inc. · Executive Compensation

$3.62 +0.00 (+0.00%) At close · Nov 12

Market Cap

$5.29M

1.46M

Volume · Nov 12 2870 Avg daily vol (3M) 9663

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Climaco	Former Chief Executive Officer	$580,000	—	—	$269,591	$319,000	—	$1,168,591
Christopher Downs	Senior Vice President – Finance, (Former Chief Financial Officer)	$450,000	—	—	$134,809	$144,000	—	$728,809
Sandra L. Silberman	Former Chief Medical Officer	$495,000	—	—	$67,418	$158,400	—	$720,818

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John M. Climaco	CEO	$525,000	—	—	$292,817	$285,863	—	$1,103,680
John Climaco	Chief Executive Officer	$525,000	—	—	$292,817	$285,863	—	$1,103,680
Christopher Downs	Chief Financial Officer	$340,000	—	—	$146,410	$134,640	—	$621,050
Christopher S. Downs	CFO	$340,000	—	—	$146,410	$134,640	—	$621,050
Sandra L. Silberman	Chief Medical Officer	$200,000	—	—	$73,205	$88,436	—	$361,641

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John M. Climaco	CEO	$525,000	—	$20,688	$18,022	$60,638	—	$624,348
John Climaco	Chief Executive Officer	$525,000	—	$20,688	$18,022	$60,638	—	$624,348
Christopher Downs	Chief Financial Officer	$340,000	—	$10,344	$9,011	$42,160	—	$401,515
Christopher S. Downs	CFO	$340,000	—	$10,344	$9,011	$42,160	—	$401,515
Sandra L. Silberman	Chief Medical Officer	$200,000	—	$4,784	$4,168	$61,200	—	$270,152

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John M. Climaco	CEO	$525,000	—	—	$14,178	$288,750	—	$827,928
John Climaco	Chief Executive Officer	$525,000	—	—	$14,178	$288,750	—	$827,928
Christopher Downs	Chief Financial Officer	$340,000	—	—	$5,224	$136,000	—	$481,224
Christopher S. Downs	CFO	$340,000	—	—	$5,224	$136,000	—	$481,224
Sandra L. Silberman	Chief Medical Officer	$200,000	—	—	$1,306	$80,000	—	$281,306

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Climaco	Chief Executive Officer	$525,000	—	$197,940	—	$123,000	—	$845,940
John M. Climaco	CEO	$525,000	—	$197,940	—	$123,000	—	$845,940
Christopher Downs	Chief Financial Officer	$340,000	—	$82,475	—	$58,000	—	$480,475
Christopher S. Downs	CFO	$340,000	—	$82,475	—	$58,000	—	$480,475
Sandra L. Silberman	Chief Medical Officer	$200,000	$10,000	$41,238	—	$18,000	—	$269,238

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John M. Climaco	CEO	$440,000	—	—	$937,808	$195,100	—	$1,572,908
John Climaco	Chairman and Chief Executive Officer	$440,000	—	—	$937,808	$195,100	—	$1,572,908
Christopher Downs	Chief Financial Officer	$300,000	—	—	$396,299	$94,700	—	$790,999
Christopher S. Downs	CFO	$300,000	—	—	$396,299	$94,700	—	$790,999
Sandra L. Silberman	Chief Medical Officer	$175,000	—	—	$127,058	$38,900	—	$340,958

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Climaco	Chairman and Chief Executive Officer	$213,867	$193,600	—	$806,237	—	$15,600	$1,229,304
John M. Climaco	CEO	$213,867	$193,600	—	$806,237	—	$15,600	$1,229,304
Christopher Downs	Chief Financial Officer	$40,000	$25,000	—	$1,085,708	—	$3,407	$1,154,115
Christopher S. Downs	CFO	$40,000	$25,000	—	$1,085,708	—	$3,407	$1,154,115
Sandra L. Silberman	Chief Medical Officer	$23,333	$20,083	—	$229,305	—	—	$272,721

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Climaco	Chairman and Chief Executive Officer	$150,000	—	—	—	—	$14,300	$164,300
John M. Climaco	CEO	$150,000	—	—	—	—	$14,300	$164,300

Executive changes

Person	Role	Change	Effective	Filed
Amy Mahery	director	Appointed	2026-09-30	2026-10-02
Rami Levin	director	Appointed	2026-09-30	2026-10-02
Jeffrey Keyes	director	Appointed	2026-09-30	2026-10-02
Michal Fisher	director	Appointed	2026-09-30	2026-10-02
Bettina Cockroft	director	Appointed	2026-09-30	2026-10-02
Faith Charles	director	Appointed	2026-09-30	2026-10-02
Michal Fisher	independent member of the Company's Board	Appointed	2026-05-04	2026-05-04
Jerzy (George) Gumulka	member of the Company's Board of Directors	Resigned	2026-05-04	2026-05-04
Lynne Kelley	Chief Medical Officer	Appointed	2026-03-02	2026-03-02
Christopher Downs	Chief Financial Officer	Resigned	2026-03-02	2026-02-17
Christopher Downs	Senior Vice President – Finance	Appointed	2026-03-02	2026-02-17
Steve O'Loughlin	Chief Financial Officer	Appointed	2026-03-02	2026-02-17
John Climaco	member of the Company's Board of Directors	Resigned	2025-12-16	2025-12-17
John Climaco	chief executive officer	Resigned	2025-12-16	2025-12-17
Rami Levin	member of the Company's Board of Directors	Appointed	2026-01-01	2025-12-17
Rami Levin	Chief Executive Officer and President	Appointed	2026-01-01	2025-12-17
Amy Mahery	Director	Appointed	2025-11-17	2025-11-21
Bettina Cockroft	Director	Appointed	2025-11-17	2025-11-21
Faith Charles	Director	Appointed	2025-11-17	2025-11-21
Jeffry R. Keyes	Director	Appointed	2025-11-17	2025-11-21
Jerzy (George) Gumulka	Director	Appointed	2025-11-17	2025-11-21
John Climaco	Director	Appointed	2025-11-17	2025-11-21
Amy Mahery	Director	Appointed	2024-04-30	2024-05-03
Faith Charles	Director	Appointed	2024-04-30	2024-05-03
Bettina Cockroft	Director	Appointed	2024-04-30	2024-05-03

Leadership

Rami Levin CEO, Board Member
Faith Charles Chairman, Board Member
Steve O'Loughlin CFO
Eric Faulkner CTO
Amy Mahery Board Member
Bettina Cockroft Board Member
Bettina M. Cockroft, M.D., M.B.A. Board Member
Faith L. Charles Board Member
Jeff Keyes Board Member
Jeffrey Keyes Board Member
Jeffry R. Keyes Board Member
Jerzy (George) Gumulka Board Member
John Climaco Board Member
Michal Fisher Board Member

Key facts CIK 1729427 CUSIP 18978H508 13F (30d) 9 filings 5 filers Visit website Investor relations